Use the Search Fields to Find Information
Page 15 of 357
Topical Use of Cannabis sativa L. Biochemicals
Abstract Cannabis sativa L. plant is currently attracting increasing interest in cosmetics and dermatology. In this review, the biologically active compounds of hemp are discussed. Particularly
October 30, 2024
Topical cannabis-based medicines – A novel adjuvant treatment for venous leg ulcers: An open-label trial
Please use this link to access this publication. Abstract Venous leg ulcers are highly prevalent lower limb integumentary wounds that remain challenging to heal despite
July 18, 2025
Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series
Abstract Background Chemotherapy-induced peripheral neuropathy is a common and often severe side effect from many chemotherapeutic agents, with limited treatment options. There is no literature
April 1, 2024
Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease
Abstract Purpose Dry eye disease (DED) is a multifactorial disease, with limitations regarding efficacy and tolerability of applied substances. Among several candidates, the endocannabinoid system with its receptors
January 15, 2024
Tolerance to the Memory Disruptive Effects of Cannabinoids Involves Adaptation by Hippocampal Neurons
The effects of chronic exposure to cannabinoids on short-term memory in rats were assessed during repeated daily injections of an initially debilitating dose (3.75 mg/kg)
September 19, 2019
Tolerance for specific negative affective states and coping-oriented cannabis use motives among college student cannabis users
Please use this link to access this publication. Abstract Objective The current study examined the unique predictive ability of tolerance of specific negative affective states
March 14, 2024
Tolerability of High-Dose Oral Δ9-THC: Implications for Human Laboratory Study Design
Please use this link to access this publication. Abstract Background: Δ9-tetrahydrocannabinol (THC), the primary intoxicating compound in cannabis, has been tested extensively in controlled administration human
March 13, 2024
Tissue Engineering of Cartilage; Can Cannabinoids Help?
This review discusses the role of the cannabinoid system in cartilage tissue and endeavors to establish if targeting the cannabinoid system has potential in mesenchymal
September 19, 2019
Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials
Abstract Objective We conducted a post hoc analysis of two randomized controlled trials, GWPCARE1 (NCT02091375) and GWPCARE2 (NCT02224703), to estimate the time to onset of
April 23, 2024
Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6
Abstract Objective To estimate the timing of cannabidiol (CBD) treatment effect (seizure reduction and adverse events [AEs]) onset, we conducted a post hoc analysis of
January 18, 2024
Page 15 of 357